[HTML][HTML] Immunogenicity of Ad26. COV2. S vaccine against SARS-CoV-2 variants in humans
…, RS Baric, M Le Gars, J Sadoff, AM de Groot… - Nature, 2021 - nature.com
The Ad26.COV2.S vaccine 1 , 2 – 3 has demonstrated clinical efficacy against symptomatic
COVID-19, including against the B.1.351 variant that is partially resistant to neutralizing …
COVID-19, including against the B.1.351 variant that is partially resistant to neutralizing …
Immunogenicity of the Ad26. COV2. S Vaccine for COVID-19
KE Stephenson, M Le Gars, J Sadoff, AM de Groot… - Jama, 2021 - jamanetwork.com
Importance Control of the global COVID-19 pandemic will require the development and
deployment of safe and effective vaccines. Objective To evaluate the immunogenicity of the Ad26…
deployment of safe and effective vaccines. Objective To evaluate the immunogenicity of the Ad26…
Safety and immunogenicity of the Ad26. COV2. S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
…, G Shukarev, D Heerwegh, C Truyers, AM de Groot… - MedRxiv, 2020 - medrxiv.org
BACKGROUND The ongoing coronavirus disease (COVID)-19 pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be controlled by an …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be controlled by an …
Human milk extracellular vesicles target nodes in interconnected signalling pathways that enhance oral epithelial barrier function and dampen immune responses
…, A Giovanazzi, AM de Groot… - Journal of …, 2021 - Wiley Online Library
Maternal milk is nature's first functional food. It plays a crucial role in the development of the
infant's gastrointestinal (GI) tract and the immune system. Extracellular vesicles (EVs) are a …
infant's gastrointestinal (GI) tract and the immune system. Extracellular vesicles (EVs) are a …
[HTML][HTML] First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26. Filo and MVA …
…, A Marit de Groot, MG Pau, J Hendriks, SC De Rosa… - PloS one, 2022 - journals.plos.org
Background Though clinically similar, Ebola virus disease and Marburg virus disease are
caused by different viruses. Of the 30 documented outbreaks of these diseases in sub-…
caused by different viruses. Of the 30 documented outbreaks of these diseases in sub-…
[HTML][HTML] Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an …
AM de Groot, G Du, J Mönkäre, ACM Platteel… - Journal of Controlled …, 2017 - Elsevier
The skin is an attractive organ for immunization due to the presence of a large number of
epidermal and dermal antigen-presenting cells. Hollow microneedles allow for precise and non-…
epidermal and dermal antigen-presenting cells. Hollow microneedles allow for precise and non-…
Durable antibody responses elicited by 1 dose of Ad26. COV2. S and substantial increase after boosting: 2 randomized clinical trials
…, N Vaissiere, D Heerwegh, C Truyers, AM de Groot… - Vaccine, 2022 - Elsevier
Background Ad26.COV2.S is a well-tolerated and effective vaccine against COVID-19. We
evaluated durability of anti-SARS-CoV-2 antibodies elicited by single-dose Ad26.COV2.S and …
evaluated durability of anti-SARS-CoV-2 antibodies elicited by single-dose Ad26.COV2.S and …
Durability of antibody responses elicited by a single dose of Ad26. COV2. S and substantial increase following late boosting
…, N Vaissiere, D Heerwegh, C Truyers, AM de Groot… - MedRxiv, 2021 - medrxiv.org
Background We evaluated the durability of SARS-CoV-2 antibody levels elicited by the single
dose Janssen COVID-19 vaccine, Ad26.COV2.S, and the impact on antibody responses of …
dose Janssen COVID-19 vaccine, Ad26.COV2.S, and the impact on antibody responses of …
Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation
M Kristensen, AM de Groot, J Berthelsen… - Bioconjugate …, 2015 - ACS Publications
Delivery of therapeutic peptides and proteins by the use of cell-penetrating peptides (CPPs)
as carriers has been suggested as a feasible strategy. The aim of the present study was to …
as carriers has been suggested as a feasible strategy. The aim of the present study was to …
[HTML][HTML] Immunogenicity testing of lipidoids in vitro and in silico: modulating lipidoid-mediated TLR4 activation by nanoparticle design
AM de Groot, K Thanki, M Gangloff… - … Therapy-Nucleic Acids, 2018 - cell.com
Therapeutics based on small interfering RNA (siRNA) have promising potential as antiviral
and anti-inflammatory agents. To deliver siRNA across cell membranes to reach the RNAi …
and anti-inflammatory agents. To deliver siRNA across cell membranes to reach the RNAi …